A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous (IV) ACHN-975 in Normal Healthy Volunteers
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
Durham |
| State: |
|
North Carolina |
| Zip Code: |
|
27705 |
| Conditions: |
|
Healthy Volunteer |
| Purpose: |
|
This is a double-blind, randomized, placebo-controlled, single ascending dose study to
assess the safety, tolerability, and PK of ACHN-975 in normal healthy volunteers. This study
will take place in the US at one clinical site.
|
| Study Summary: |
|
|
| Criteria: |
|
Key Inclusion Criteria:
- Body weight between 40 and 100 kilograms (between ~88 pounds and ~220 pounds)
- Use of contraception
- Stable health
- Negative tests for alcohol, tobacco, and drugs of abuse
Key Exclusion Criteria:
- History of clinically significant disease
- Pregnancy
|
| NCT ID: |
|
NCT01597947 |
| Primary Contact: |
|
Study Director
Medical Director
Achaogen, Inc.
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Durham, North Carolina 27705
United States
There is no listed contact information for this specific location.
Site Status: N/A |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 19, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|